Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1995 May;4(3):222–228. doi: 10.1155/S0962935195000366

An increase in nitric oxide produced by rat peritoneal neutrophils is not involved in cell apoptosis

I M Fierro 1, C Barja-Fidalgo 1, R M Canedo 1, F Q Cunha 2,✉, S H Ferreira 2
PMCID: PMC2365636  PMID: 18475643

Abstract

Polymorphonuclear neutrophils (PMN) obtained from carrageenin-stimulated peritoneal cavities of rats, but not blood PMN, spontaneously produced nitric oxide (NO) when incubated in vitro. Incubation of the cells with the NO synthase inhibitors, L-imino-ethyl-L-ornithine (L-NIO) or NG-monomethyl-L-arginine (L-NMMA), inhibited NO production. This inhibition could be reversed by L-arginine. Incubation of PMN with lipopolysaccharide (LPS) failed to enhance NO production. Pretreatment of the rats with dexamethasone (DEXA) prior to carrageenin injection or incubation of PMN with the glucocorticoid in vitro partially inhibited the spontaneous release of NO. On the other hand, when PMN obtained from DEXA pretreated rats were incubated in vitro with DEXA, NO synthase activity and hence NO generation were almost abolished. A similar inhibition was also observed following the addition of L-NIO or cycloheximide to cultures of carrageenin-elicited PMN. The NO production by PMN did not appear to be related to cell viability or apoptosis. Indeed, neither the blockade of NO generation by L-NIO nor the incubation of the neutrophils with a NO donor, S-nitroso-acetylpenicillamine (SNAP) modified the pattern of LDH release or DNA fragmentation. In summary, it appears that PMN migration triggers a continuous NO synthesis, and that NO produced by these cells is not related to their apoptosis.

Full Text

The Full Text of this article is available as a PDF (872.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benveniste E. N., Vidovic M., Panek R. B., Norris J. G., Reddy A. T., Benos D. J. Interferon-gamma-induced astrocyte class II major histocompatibility complex gene expression is associated with both protein kinase C activation and Na+ entry. J Biol Chem. 1991 Sep 25;266(27):18119–18126. [PubMed] [Google Scholar]
  2. Cohen P. Signal integration at the level of protein kinases, protein phosphatases and their substrates. Trends Biochem Sci. 1992 Oct;17(10):408–413. doi: 10.1016/0968-0004(92)90010-7. [DOI] [PubMed] [Google Scholar]
  3. Gumina R. J., Freire-Moar J., DeYoung L., Webb D. R., Devens B. H. Transduction of the IFN-gamma signal for HLA-DR expression in the promonocytic line THP-1 involves a late-acting PKC activity. Cell Immunol. 1991 Dec;138(2):265–279. doi: 10.1016/0008-8749(91)90152-2. [DOI] [PubMed] [Google Scholar]
  4. Hepler J. R., Gilman A. G. G proteins. Trends Biochem Sci. 1992 Oct;17(10):383–387. doi: 10.1016/0968-0004(92)90005-t. [DOI] [PubMed] [Google Scholar]
  5. Ina Y., Koide Y., Nezu N., Yoshida T. O. Regulation of HLA class II antigen expression: intracellular signaling molecules responsible for the regulation by IFN-gamma and cross-linking of Fc receptors in HL-60 cells. J Immunol. 1987 Sep 1;139(5):1711–1717. [PubMed] [Google Scholar]
  6. Liscovitch M. Crosstalk among multiple signal-activated phospholipases. Trends Biochem Sci. 1992 Oct;17(10):393–399. doi: 10.1016/0968-0004(92)90007-v. [DOI] [PubMed] [Google Scholar]
  7. Roullet J. B., Xue H., Pappu A. S., Roullet C., Holcomb S., McCarron D. A. Mevalonate availability and cardiovascular functions. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11728–11732. doi: 10.1073/pnas.90.24.11728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Schafer W. R., Kim R., Sterne R., Thorner J., Kim S. H., Rine J. Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans. Science. 1989 Jul 28;245(4916):379–385. doi: 10.1126/science.2569235. [DOI] [PubMed] [Google Scholar]
  9. Scher M. G., Beller D. I., Unanue E. R. Demonstration of a soluble mediator that induces exudates rich in Ia-positive macrophages. J Exp Med. 1980 Dec 1;152(6):1684–1698. doi: 10.1084/jem.152.6.1684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Steeg P. S., Moore R. N., Johnson H. M., Oppenheim J. J. Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity. J Exp Med. 1982 Dec 1;156(6):1780–1793. doi: 10.1084/jem.156.6.1780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Vassiliadis S., Athanassakis I. Type II interferon may be a potential hazardous therapeutic agent during pregnancy. Br J Haematol. 1992 Dec;82(4):782–783. doi: 10.1111/j.1365-2141.1992.tb06967.x. [DOI] [PubMed] [Google Scholar]
  12. Vassiliadis S., Kyrpides N., Stravopodis D., Grigoriou M., Athanassakis I., Papamatheakis J. Investigation of intracellular signals generated by gamma-interferon and IL-4 leading to the induction of class II antigen expression. Mediators Inflamm. 1993;2(5):343–348. doi: 10.1155/S096293519300047X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Vassiliadis S., Tsoukatos D., Athanassakis I. Interferon-induced class II expression at the spongiotrophoblastic zone of the murine placenta is linked to fetal rejection and developmental abnormalities. Acta Physiol Scand. 1994 Aug;151(4):485–495. doi: 10.1111/j.1748-1716.1994.tb09771.x. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES